Emna Gouider Belhadjali/WFH
Sep 26, 2025, 14:39
Dr. Emna Gouider Belhadjali at 4th International Conference on Hemophilia and Rare Bleeding Disorders
MENA Conference shared a post on LinkedIn:
“How is Glanzmann’s thrombasthenia being addressed in North Africa?
Join Dr. Emna Gouider Belhadjali at the Middle East and North Africa (HEMNET) Session during the 4th International Conference on Hemophilia and Rare Bleeding Disorders, taking place on 11–12 October 2025 at the Grand Hyatt Hotel, Abu Dhabi, UAE, as she presents “Glanzmann in North Africa.””
Stay up to date with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis